Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank description Network Comparison Type Value Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 551 to 600 of 6456 in total 
Value Type: Measured
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
276\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
699.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1894.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1194.63\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative rna-binding protein 15 (rna binding motif protein 15) (one-twenty two protein). [source:swissprot;acc:q96t37]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20953\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
277\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial import receptor subunit tom20 homolog (mitochondrial 20 kda outer membrane protein) (outer mitochondrial membrane receptor tom20). [source:swissprot;acc:q15388]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8600.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9792.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1192.47\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of g-protein signaling 20 (rgs20) (regulator of gz- selective protein signaling 1) (gz-selective gtpase-activating protein) (g(z)gap). [source:swissprot;acc:o76081]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20953\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
278\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal farnesylated protein (33 kda housekeeping protein) (peroxin 19). [source:swissprot;acc:p40855]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8600.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9792.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1192.47\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor lbx1. [source:swissprot;acc:p52954]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.20953\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
279\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mosaic protein lgn. [source:swissprot;acc:p81274]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 3b subunit 3 (spliceosome associated protein 130) (sap 130) (sf3b130) (pre-mrna splicing factor sf3b 130 kda subunit). [source:swissprot;acc:q15393]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4771.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5961.43\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1190.22\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
280\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14a; 17-kda pkc-potentiated inhibitory protein of pp1. [source:refseq;acc:nm\_033256]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1188\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of g-protein signaling 17 (rgs17). [source:swissprot;acc:q9ugc6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.20953\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
281\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(o), alpha subunit 1. [source:swissprot;acc:p09471]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
microfibril-associated glycoprotein 4 precursor. [source:swissprot;acc:p55083]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
677.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1188\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
282\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 14d; pkc-dependent pp1 inhibitory protein. [source:refseq;acc:nm\_017726]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rap1 gtpase-activating protein 1 (rap1gap). [source:swissprot;acc:p47736]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3119.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2579.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20953\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
283\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ficolin 2 precursor (collagen/fibrinogen domain-containing protein 2) (ficolin-b) (ficolin b) (serum lectin p35) (ebp-37) (hucolin) (l- ficolin). [source:swissprot;acc:q15485]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1188\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
polymerase (dna directed) iota; rad30 (s. cerevisiae) homolog b; polymerase (dna-directed), iota. [source:refseq;acc:nm\_007195]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5221.28\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6314.35\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.20935\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
284\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
paxillin. [source:swissprot;acc:p49023]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1188\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
285\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 4 gamma, 3. [source:refseq;acc:nm\_003760]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4068.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5252.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1184.04\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
poly(a) polymerase alpha (ec 2.7.7.19) (pap) (polynucleotide adenylyltransferase alpha) (fragment). [source:swissprot;acc:p51003]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
23326.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
19296.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20885\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
286\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec5. [source:swissprot;acc:q96kp1]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
23316\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
19288.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20878\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rna-binding protein. [source:refseq;acc:nm\_019027]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4069.83\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
5252.17\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1182.34\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
287\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apobec-1 complementation factor isoform 1; apobec-1 stimulating protein; apo-b rna editing protein. [source:refseq;acc:nm\_014576]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
poly(a) polymerase gamma (ec 2.7.7.19) (pap gamma) (polynucleotide adenylyltransferase gamma) (srp rna 3' adenylating enzyme). [source:swissprot;acc:q9bwt3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
23303.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
19279.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.2087\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
288\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 73 kda subunit (cpsf 73 kda subunit). [source:swissprot;acc:q9ukf6]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
23422.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
19380.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20857\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ns1-associated protein 1. [source:refseq;acc:nm\_006372]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4069.83\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
5252.17\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1182.34\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
289\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein r (hnrnp r). [source:swissprot;acc:o43390]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm6 (sm protein f). [source:swissprot;acc:q9y4y8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4682.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5646.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20571\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
290\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 4 gamma (eif-4-gamma) (eif- 4g) (eif4g) (p220). [source:swissprot;acc:q04637]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4071.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5251.75\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1180.65\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tuftelin-interacting protein 11 (hspc006). [source:swissprot;acc:q9ubb9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4991.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6014.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20487\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
291\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pallidin; pallid (mouse) homolog, pallidin. [source:refseq;acc:nm\_012388]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5894.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7073.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1178.9\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
44490.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
36927.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20481\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
292\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleotide-binding protein 1 (nbp 1). [source:swissprot;acc:p53384]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4641.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5588.75\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20419\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase, interferon-inducible double stranded rna dependent activator; protein activator of the interferon-induced protein kinase. [source:refseq;acc:nm\_003690]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
950.561\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2108.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1157.96\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
293\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleotide binding protein 2 (nbp 2). [source:swissprot;acc:q9y5y2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4641.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5588.75\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20419\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein e (snrnp-e) (sm protein e) (sm-e) (sme). [source:swissprot;acc:p08578]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4512.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5655.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1143.33\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
294\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage stimulation factor subunit 3; cleavage stimulation factor, 3' pre-rna, subunit 3, 77kd. [source:refseq;acc:nm\_001326]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
22515.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18702.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20387\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein f (snrnp-f) (sm protein f) (sm-f) (smf). [source:swissprot;acc:q15356]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4512.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5655.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1143.33\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
295\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atlastin; guanylate-binding protein 3. [source:refseq;acc:nm\_015915]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5720.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4577.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1142.75\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator-like 1 (ralgds-like 1). [source:swissprot;acc:q9nzl6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13261.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11017.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20368\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
296\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear transcription factor y subunit gamma (nf-y protein chain c) (nuclear factor yc) (nf-yc) (ccaat-binding transcription factor subunit c) (cbf-c) (transactivator hsm-1/2). [source:swissprot;acc:q13952]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3620.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4763.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1142.57\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 3a subunit 2 (spliceosome associated protein 62) (sap 62) (sf3a66). [source:swissprot;acc:q15428]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4911.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5909.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20306\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
297\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat-binding transcription factor subunit b (cbf-b) (nf-y protein chain a) (nf-ya) (caat-box dna binding protein subunit a). [source:swissprot;acc:p23511]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3620.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4763.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1142.57\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
krueppel-like factor 5 (intestinal-enriched krueppel-like factor) (colon krueppel-like factor) (transcription factor bteb2) (basic transcription element binding protein 2) (bte-binding protein 2) (gc box binding protein 2). [source:swissprot;acc:q13887]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4911.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5909.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20306\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
298\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adrenodoxin, mitochondrial precursor (adrenal ferredoxin) (hepatoredoxin) (ferredoxin 1). [source:swissprot;acc:p10109]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8268.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9405.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1137.66\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm2 (small nuclear ribonuclear protein d homolog) (g7b) (snrnp core sm-like protein sm-x5). [source:swissprot;acc:q9y333]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4633.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5572.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20262\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
299\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba395l14.12 (novel protein similar to small nuclear ribonucleoprotein polypeptide a' (snrpa1)). [source:sptrembl;acc:q9nu36]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4914.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5907.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20203\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
metaxin 1. [source:swissprot;acc:q13505]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
9327.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10442.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1114.62\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
300\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor iiib 90 kda subunit (tfiiib90) (htfiiib90) (b- related factor 1) (hbrf) (tata box-binding protein-associated factor, rna polymerase iii, subunit 2) (taf3b2). [source:swissprot;acc:q92994]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4446.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5553.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1107.07\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u2 small nuclear ribonucleoprotein a' (u2 snrnp-a'). [source:swissprot;acc:p09661]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4914.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5907.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.20203\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/